61th of Japanese Society of Neurology（CORONA light style Revised Program 10 version)
Directors room
(Room 403)

August 31 (Mon), 2020
Building

Floor

4Ｆ

Room

7:00

8:00

9:00

10:00

OkayamaConvention
CenterRoom 2 (#407)(J) Hot topics 2 Studies on multifactorialdiseases using "Big Data" (Kamatani,
Ishiura=Kamatani, Satake, Atsuta,
Shigemizu, Takada)(J) LS-2 Dainippon-

Web casting →(J) Emergent symposium for(E) WFN
Ope neurologists in CORONA 1 (Abe,CORONAning Hashimoto=Kimura, Hashimoto, Sasaki,
reportKawamoto)(E) Symposium 1 A novel approach todeciper molecualr mechanisms of humandemyelinating diseases (Nakatsuji,
Yamasaki=Matsushita, Misu, Liu,
Yamasaki)(J) Symposium 2 Current status andperspectives of the Neuro-ICU in theworld Neurology (Nagayama, Ariga = Ohta,
Nagayama, Kuroda, Higashihara, Ariga)

Room 4 (#301)

Room 6

Business Meeting(Reception Hall)(J/E) Web-join(J) Symposium 3 Recent advances inneuroimaging in PSP / CBD (Maruyama,
Shimada=Shimada, Sako, Tokumaru,
Matsuura)

Room 7(Exhibition Hall)

Okayama
Doctors Center

1Ｆ

Postes/Exhibitions

4Ｆ

Room 8 (#401)(J) Web-cast

4Ｆ

Hotel ANA
Okayama

Lecture Marathon Web casting →OKayamaInternational
Center(#Miki MemorialHall) (E) Web-

(E) WFN (E) Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｅｄｕｃａｔｉｏｎ
CORONA Ｃｏｕｒｓｅ 1 (Yamashita, Kusuma=Liu,
report Kusuma, Yamashita, Postuma)

English only Web casting →(J) Symposium 5 Treatment strategy
update for MS and NMOSD (Yokoyama,
Nakahara=Nakashima, Okuno, Ochi,
Yoshikura, Nakahara)(J) Symposium 6 Integration of theinsights from various ALS models forpreclinical study (Urushitani,
Iguchi=Furukawa, Ueyama, Iguchi, Suzuki,
Ohkubo)Payed-Web casting for education(pink areas) →(#Kyokusui)Room 12(#Event Hall)

5Ｆ

Room 13 (#1)

2F

Room 14

B1F(J) Lecture marathon 2
Advanced neurodiagnosis
with PET(Yamaguchi=Kameyama)

Room 9 (#402)(J) Web-cast

8Ｆ(Sato, Takemoto)(J) Lecture marathon 1
Neuroimagings ofneurodegenerative disease(Deguchi=Yabe)(J) Symposium 7 Mitochondrial diseases
UPDATE (Sunada, Goto=Goto, Yoneda,
Nishino, Sunada)(#Int'l Meeting)Room 15(#Reception Hall)

Hotel Granvia
OkayamaDirectors
Photo

CORONA
moderate-severe
stages15 e-posters
presentation(J) Symposium 4 The science ofvertigo/dizziness (Joukura,
Fukutake=Shibata, Fukutake, Jokura,
Joukura)cast
Room 111Ｆ

Posterpreparation

Exhibition

Room 102Ｆ

13:00(J) LS-1 GE/日本

Room 5 (#302)

2Ｆ

12:00

(E) Hot topics 1 Non-invasive
neuromodulation (Terao, Hanajima=Mima,
Ogata, Shimizu, Nishimura)

cast

3Ｆ

11:00

Room 1 (#405)(E) Web-join

Room 3 (MainHall) (E/J) Web-

Relaxing and Tea/Coffee (Room 403/404)

Lunch Seminar Companies (Room 403/404)

MESI: AbPET（Iwatsubo＝
Tsukamoto, Tokuda）

Sumitomo: Fabry（Sekishima＝Ito, Yagita）(J) LS-3 KyowaKirin: PD（Hasegawa＝
Nomoto）(J) LS-4 Novartis:
MS and dementia（Ochi＝Niino, Fujimori）(J) LS-5 Asteras:
Sleep disorder（Yamashita＝Oka)(J) LS-6 Protosera:
Dementia biomarker（Kusunoki＝Abe）(J) LS-7 Illumina: ADgene（Shoji＝Satake）

14:00

15:00

16:00

as of August 25, 2020
17:00

18:00

(E) Hot topics 3 Dawn of new era:
management of migraine headache(Hirata, Terayama=Igarashi, Dodick,Shibata, Danno, Ushida)(E+J) Hot topics 5 Future drug development forneurological disorders by major pharmaceuticalcompanies and Public Private Partnership (Yokota,
Takahashi=Nagai, Senba, Nakanishi, Davis,
Sandrock)(J) ES-1 Chugai: IL-(J) Hot topics 4 The future of neurology
utilized AI and BMI (Takizawa,
Iguchi=Hanakawa, Tsutsui, Mihara, Iguchi
Yamaguchi)(J) Hot topics 6 Next steps to overcome
proteinopathies (Shimada,
Nonaka=Nonaka, Okuzumi, Iwata,
Uematsu, Ishigaki)(J) ES-2 Eisai:(E) From the local to the world 1 (FTD, Miyosi,
Edaravone, Asidan, Optineurin, Taurin, Osaka AD)(Kuzuhara, Toda = Abe, Nishino-Kawai-Aoki, Abe,
Ohta-Nagai, Kawakami, Sunada, Kutoku)(J) Special lecture 1(J) Special lecture 2 From
Future stroke as basic andPsychiatry tp Neurology
clinical sciences(Kaji=Takeda)(Minematsu = Uchiyama)(J) Symposium 8 CIDP: From bench to
bedside (Misawa, Kuwahara=Iijima,
Kuwahara, Sano, Ogata)(J) Symposium 14 Cutting edge of thepathogensis and treatment in peripheral
neuropathies (Kanda, Koike=Misawa,
Kaida, Okamoto, Takeshita)(J) Symposium 9 Clinical ethics
consultations help autonomous decision
making by patiens with intractablediseases (Inaba, Nagano=Asai, Inaba, Itai,
Ito)(J) Symposium 10 Neuroimaging of
neurological disorders presenting
parkinsonism (Shimohama, Hanyu=Suzuki,
Yamazaki, Ito, Sakurai)(J) Symposium 11 The cutting edge ofimaging research for theneurodegenerative factors (Yoneda,
Ikawa=Ouchi, Ikawa, Takado, Kikuchi)

6 antagonism for NMOSD（Yokoyama＝Araki）

advanced PD (Matsukawa＝Hatano）(E) WFN
CORONA
report(J) ES-3 Cosmic:
anti-ＶＧＣＣ Ab （Takamori＝Motomura）(J) Symposium 15 Overcoming refractoryheadaches (Takeshima, Suzuki N=Ito, Imai,
Kikui, Tatsumoto, Suzuki M)(E) Symposium 16 Autoimmune epilepsy（Ikeda, Matsumoto=Bo Sun, Sakamoto,
Uchida, Jin）

(E) ES-4 Eisai:(J) Symposium 17 Dream of ideal medicalcare for intractable diseases (Kira,
Ogino=Kira, Kakee, Itoh, Ogino)(J) ES-5 Novartis:

Biomarker for PD and AD(Mochiduki, Nagai=Miller）

MS (Fujihara＝Kira）

Poster on abstract book （Pe-01-1 ～ Pe-33-10、AP-01-1 ～ AP02-8、APe-01-1 ～ APe-01-8、StP-01-1 ～ StP-03-10） Total 339 Removal
posters (J) Lecture marathon 4 (J) Lecture marathon 5 (J) Lecture marathon 6(J) Lecture marathon 3(J) LS-8 Biogen:
SMA（Tanaka＝Ayaki）(J) LS-9
Jansen/Integra: Dementia（Iwata＝Kazui）(J) LS-10 Bayer: Af(Toyoda＝Matoba, Kimura）(J) LS-11 Stryker:
Acute stroke therapy（KItagawa＝Kimura, Todo）(J) LS-12 Takeda:
PD (Saiki＝Fujioka Maeda）

Panel preparation(J) Educational course 1 Small vessel
diseases (Nakajima, Miwa=Yakushiji,
Nagakane, Takagi, Ueda, Miwa)(J) LS-13 Alnylam:(J) Educational course 2 Best headache
management (Kowa, Imai=Imai, Ishizaki,
Kikui, Kudo)(J) LS-14 Tanabe

TTR（Sobue＝Ando）

Mitsubishi: MS (MIsu＝Isobe）(J) ES-6 Otsuka:

Proper diagnosis for
New guideline 2018 ofTranscranial magnetic
Patent getting for
peripheral neuropathy
Parkinson's diseasestimulation (Furuya =neurologists(Yamada=Kanda)(Tomimoto=Maeda)
Hanajima)(Maruyama=Shimohata)(J) Symposium 12 The next-generation(J) Symposium 18 New development of
ALS clinical trials proposed from the 5evolving intractable muscle diseases
running investigator-initiated clinical(Sugie, Hayashi=Nishino, Aoki, Hayashi,
trials in Japan (Aoki, Aizawa=Warita,
Sugie)
Aizawa, Izumi, Ito, Inoue)(E) Emerging Asian Neurology 1(Abe, Tan = Lee, Sugiu, Tan,
Tian, Wei, Kusuma)(E) Vas-Cog Asia/Japan Joint
Symposium (Morishita, Lee = Hu,
Senanarong, Yamashita,Tian, Ong, Ihara)

Migraine （Hirata＝Takeshima, Takahashi）(E) WFN Special
Lecture （Kaji＝Tissa
Wijeratne）((J) Certified neurologist promoting seminar (J) Certified neurologist promoting seminar
1:EEG, Epilepsy, Cognition (Jin, Otsuki)
2: Muscle pathology and Stroke (Shimizu,(3,000 yen for 2h*2 sessions)
Hashimoto) (3,000 yen for 2h*2 sessions)(J) Symposium 13 Dystonia update(Kuwabara, Hasegawa=Hasegawa, Chiken,
Kumada, Taniguchi)

Mitsubishi: ALS (Aoki＝
Doyu）(J) Symposium 19 The development forJapan's prion disease research leadingin the world (Yamada, Sato=Sanjo, Fujita,
Sato, Iwasaki, Tsuboi)(J) Educational course 5 Principles ofneuropathology (Uchihara, Takeda=Toyoshima, Kawakatsu, Riku, Shishido)(J) Educational course 6 Diagnosing
vertigo and diziness for neurologists(Joukura, Nanri =Nanri, Goto, Joukura,
Mimura)Directors Board meeting (4F)

Sponsor only channel A→(J) LS-1 Exhi (J) LS-3 Kyowa-Kirin:
Exhibition GE/日本MESI: bitioi PD（Hasegawa＝Nomoto）
video AbPETn（Iwatsubo＝
Tsukamoto,Sponsor only channel B→

vide(J) LS-14(J) ES-1 Chugai: IL-6
Exhibition Tanabe-Mitsubishi: antagonism for NMOSD
video MS (MIsu＝Isobe） （Yokoyama＝Araki）(J) LS-5 (J) LS-6 (J) LS-7 (J) LS-8 Biogen: Exhi (J) LS-10 Bayer: (J) LS-11(J) LS-12 Takeda: PD
bitioi Af (Toyoda＝Novartis: MS Asteras:
Protosera:
Illumina: AD SMA（Tanaka＝
Stryker: Acute(Saiki＝Fujioka Maeda）
nand dementia Sleep
Dementiagene（Shoji Ayaki）
Matoba, Kimura）
stroke therapy（Ochi＝disorderbiomarker＝Satake）（KItagawa＝Kimura,vide(J) ES-2 Eisai:(J) ES-3 Cosmic: (E) ES-4 Eisai:(J) ES-5 Novartis: MS (J) ES-6
(E) ES-7 Biogen/Eisai:
advanced PD (Matsukawa＝ anti-ＶＧＣＣ Ab
Biomarker for PD and AD(Fujihara＝Kira）
Otsuka: Migraine
Natarizmab （Nomura＝Hatano）（Takamori＝(Mochiduki/Nagai, tandem）（Hirata＝
Butskeven, Ho）
Motomura）
Takeshima,(J) LS-4(J) LS-13 Alnylam: TTR（Sobue＝Ando）(J) ES-8

Biogen/Eisai: Natarizmab（Nomura＝Butskeven, Ho）(J) ES-8 Tanaabe

History of Chugoku-shikoku area
Neurology （Panels）(J) Educational course 3 Multiple
sclerosis monitoring during disease
modifying therapy (Kira,
Sakuishi=Yokoyama, Niino, Watanabe,
Nakamura)(J) Educational course 4 Studying
dementia with case conference(Kobayashi, Nishio =Higashiyama, Iseki,
Futamura, Nishio)(E) ES-7

Exhi

Tanaabe Mitsubishi: bitioi
ALS (Aoki＝Doyu） nvide61th of Japanese Society of Neurology（CORONA light style Revised Program 10 version)
Semtember 1 (Tue), 2020
Building

Floor

4Ｆ

Room

3Ｆ

7:00

8:00

9:00

(E) Hot topics 7 Progress in functional
neuroimaging in dementia (Shimohama,
Hanyu=Ishii, Shimada, Okamura, Ouchi,
Kudo)

Room 2 (#407)(J) Hot topics 8 Teleremedicine andonline-medicine in neurology (Nozaki,
Nakamura= Nozaki, Nakamura, Hasegawa,Takeichi, Ban)

(E) WFN (J) Special lecture 3
Future science of
Web casting → CORONA Alzheimer's diseasereport (Shoji=Mori)

Room 4 (#301)(J) Symposium 21 Basic Neuropathology
for Neurologists (Murayama,
Takao=Murayama, Nishimura, Takanashi,
Takao)

Room 6(E) Symposium 22 Latest Advances in theTreatment of Ischemic Stroke (Kitagawa,Yamashita=Shichita, Ishibashi, Niizuma,
Yamashita)(J) Symposium 23 Novelneurophysiological techniques forevaluating and diagnosing neurologicalpatients (Terao, Nagamine =Kakehi,
Mitoma Hirano, Kawabata)(Reception Hall)(J/E) Web-join
Room 7(Exhibition Hall)

1Ｆ

Okayama
Doctors Center

Hotel ANA
Okayama

Room 8 (#401)(J) Web-cast

4Ｆ

Room 9 (#402)
Room 10(E) WFN

2Ｆ(#Miki MemorialHall) (E) Web-English only Web casting → CORONA Autophagy in Alzheimer's disease and Dementia

1Ｆ(#Kyokusui)Room 11(J) Web-cast

5Ｆ
2F
B1F

Lecture Marathon Web
casting →reportPayed-Web casting for
education (pink areas) →Room 12(#Event Hall)(E) Symposium 25 The Implication of(Motoi, Hamano =Hamano, Motoi, Makioka, Miki)

12:00(J) Hot topics 10 Neurotoxicology update(Shimohata, Iwata=Shimohata, Tokumoto,Ichikawa, Nakayama)(J) Cultural Lecture:
Science of Brain and Mind
(Mizusawa=Asano)(J) Symposium 27 Autoimmune
encepharitis (Kamei, Yamamura=Koga,
Hara, Kimura, Yamamura)(J) Symposium 28 Current issues oftransition from child to adult healthservices for childhood-onset neurologicaland muscular diseases (Ogata,
Saito=Mochizuki,(E)
Symposium 29Sakiyama,
PreparingTakahashi,for diseasemodifying therapies in PD – Frombiomarkers, animal models to novel
therapeutic approach (Arawaka, Sue=Lin,
Arawaka, Yamakado, Sue, Nakamori)(J) Symposium 30 Learn more basic
science for the future therapeutics(Mochizuki, Toda=Mochizuki, Yuzaki,
Koizumi, Murayama)

Posterpreparation

11 e-posters
presentation

13:00(J) LS-15 Fuji:
SPECT（Katsuno＝Miyamoto, Wada）(J) LS-16 Mylan:
Constipation （Hirayama＝
Manabe）(J) LS-17 Abbvie:
Hospital clinic relationPD（Orimo＝Fujimoto）(J) LS-18 Novartis:
MS patients (Yamasaki＝Murashima, Shimizu）(J) LS-19 Otsuka:
PD & neuroinflammation(Nagai＝Saiki, Miyazaki）(J) LS-20 TIMA
Japan: Brain supplementfor dementia（Inufusa/Abe
tandem）(J) LS-21 Dainippon
Sumitomo: DLB(Washimi＝Kowa, Kimura）(E) Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｅｄｕｃａｔｉｏｎ
Ｃｏｕｒｓｅ 2 (Mehndiratta, Yu = ,Mehndiratta, Dodick, Pasinetti, Hu)

14:00

15:00

16:00

(E) Hot topics 11 An update on diagnostic
and prognostic biomarkers in Parkinson's
disesae (Tomiyama, Maeda=Hatano,Hirayama, Tokuda, Sengoku)(J) Hot topics 12 Hot topics of spinal
cord diseases including cervical andlumbar spondylosis (Ando,
Furuya=Kameyama, Furuya, Ando, Hattori)(J) Congress (J) Generalchair lectureassembly(Hyslop=Abe) (Toda, Abe)(J) Awarder talks(Toda, Abe＝Misawa,Ando, Kamei）(E) Movement Disorders JournalInteractive Workshop (Cardoso =Cardoso, Hatano + Hattori, Yamamoto,Hatano、Watanabe)(J) Symposium 32 Non-motor symptomsof PD; Manifestation andpathomechanisms (Ito, Fujioka=Fujioka,
Saito, Sakakibara, Baba)(E) Symposium 33 New era ofneuroimaging and neurosonology(Hirabayashi, Kim DE= Nakagawara, Kim
DE, Hirabayashi)(J) Symposium 34 Personalized Medicine
for Neuro-immunological Disorders:Present and Future (Yamamura,Okamoto=Okamoto, Haysshi, Kondo,
Araki)(J) LS-22 Daiichi
Sankyo: Epilepsy（Shigeto＝Jin）(J) LS-23
Biomerieux: Meningitis（Nakashima＝Suzuki）(J) LS-24 Cosmic:
anti-gAChR（Kanda＝Nakane）(J) LS-25 Novartis:
Epilepsy（Matsumoto＝
Akamatsu）(J) Symposium 26 Pitfalls in medical
treatment for dementia patients(Tamaoka, Kuzuya=Shimada, Nagata,
Nagahama, Tanimukai, Tamaoka)(J) New guideline
Dystonia, SCA/MSA, HAM:
(Hanyu, Tobita=Mezaki, Yoshida,
Sato)(J) Educational course 7 Epilepsy orparoxysmal movement disorder ？ (Ikeda,
Ugawa=Sugiura, Iizuka, Hitomi, Ikeda,
Mima)(J) Educational course 9 Let's know more
peripheral neuropathy (Kusunoki,
Tsuji=Nodera, Shimizu, Kaida, Takashima)(E) LS-27 Eisai: AD(J) Educational course 8 Brain deathtransplantation and neurologist(Nagayama, Nishiyama=Nagayama, Yokota,
Sonoo, Akamatsu)(J) Educational course １0 Practical
headache management in neurology clinic(Tatsuoka, Nagata=Kowa, Nihira, Unno,
Akiyama)(J) LS-28(J) LS-26 Eisai: PD(Urushitani＝Takahashi,
Nagayama）

Room 14
Room 15(#Reception Hall)

Sponsor only channel A→(J) LS-16 (J) LS-17 (J) LS-18
Exhibition Mylan:
Abbvie: PD
Novartis: MS
video Constipation （Orimo＝patients (Yamasaki

Sponsor only channel B→

Exhibition
video(Ono＝Pasinetti）

Asashikasei: PE(Matsuo＝
Oji）

17:00

(J) Hot topics 14 Radiological andpathological findings of rare diseases
showing cognitive disorders (Tamaoka,
Ikeuchi=Sone, Ikeuchi, Ishii, Mizuno)(J) Joint symposium of Japan
Neurosurgery and Neurology Societies(Neuroprotection, Stereo surgery, PD,
Stroke) (Toda, Tominaga=Abe, Date,
Takahashi, Kinouchi)(J) Symposium 37 Recent advances in
temporal lobe epilepsy (Shigeto,
Jin=Terada, Akamatsu, Kato, Shimotake,
Kono)(E) Special lecture(Shoji=Hyslop）FTD &ALS(J) Life-time education lecture 4+5(dementia=Nakashima/Iwata,
epilecpsy=Ikeda/Matsumoto) 2,000 yen for 2 h,Credit 2 points(J) Symposium 36 Development of new
frontier for elucidation of multiple system
atrophy (Ohta, Wakabayashi=Wakabayashi,
Watanabe, Hasegawa)

DOAC & ESUS（Uchiyama＝Diener)(E) WFN (J) ES-10
CORONA Medtronics: Sensing
report （Tsuboi＝Kimura, Shimo）(J) ES-11 Ono: PD(Takahashi＝Takeda）(J) ES-12 IQVIA:(E) Syposium 39 The concept of MOGIgG positive diseases (Nakashima,
Misu=Waters, Kim, Kaneko, Takai, Ikeda)(J) ES-13 Alexion:(J) Symposium 40 Low power pathologists
have a high power (Iwasaki,
Uchihara=Iwasaki, Udaka, Hashizume,
Iwabuchi, Yoshida)

Removal(J) Lecture marathon 12(J) Lecture marathon 10(J) Lecture marathon 11
Let's master the principle
Current therapy for acute Molecular mechanism ofof electrophysiologicalischemic stroke
neuro-degeneration
methods(Toyoda=Fujimoto)(Takashima = Hasegawa)(Adachi=Kurokawa)(J) Symposium 35 Neurometabolic(J) Symposium 41 Neurorehabilitation for
disorders; updates on therapeutics anddegenerative neurological diseases
management (Shimohata,(Kaseda, Hayashi=Takeda, Hanajima, Miyai,
Sekijima=Sekijima, Matsukawa, Miyajima,
Nakajima)
Sunada, Tsuboi)（Web casting forchair lecture &assembly）

18:00(E) ES-9 Boeringer:(J) Symposium 38 The cutting-edge
discoveries of neurogenetics from Japan(Funayama, Satake=Sone, Ishiura, Higuchi,
Oji, Ikeda, Mishima)（E) Ｎｅｕｒｏｓｃｉｅｎｃｅ Ｆｒｏｎｔｉｅｒ Ｓ (E) WFN
ｙｍｐ 1 New approaches aimed for disease
CORONA
modifying therapies of AD and other dementias
report(Iwatsubo, Ono=Tomita, Pasinetti, Ono, Miller）(J) Symposium 42 Novel approach forpatients with acute stroke (Kimura,Fujimoto=Hirano, Sonoda, Yokota, Nagao)(J) Symposium 43 Carrier pass forneurology doctors (Izumi,
Matsuoka=Yoshino, Matsuoka, Ogasawara,
Umaki)

History of Chugoku-shikoku area Neurology （Panels）(#Int'l Meeting)as of August 25, 2020(J) Hot topics 13 Recent advances intauopathies (Tsuboi, Yabe=Yoshida, Yabe,
Fujioka, Hasegawa)

Poster on abstract book （Pj-01～ Pj-37-10) Total 347 posters(Manabe, Nagai)(J) Life-time educationlecture 1+2+3(Stroke=Kamiya/Kimura,
MS=Mitsui/Ochi, and PD=Takahashi/Hatano) 3,000 yen for 3 h, Credit 3 points

Room 13 (#1)

CORONA
moderate-severestyles

11:00(J) Lecture marathon 7(J) Lecture marathon 8(J) Lecture marathon 9
Molecular mechanism ofIntravascular catheter
Dementia management forneuro-degenerative
treatment for stroke asclinic neurologist
disorders (Onodera =neurologist(Shimohama = Kamiya)
Tanaka)(Kuzume=Kamiya)(J) Symposium 24 When should we stop(J) Symposium 31 IBM intensive course the treatment? (Fukaura,
up to date and pitfall- (Mori, Suzuki=Aoki,
Murakami=Shimizu, Maeda, Ogino,Mori, Higashihara, Kubota, Yamamoto)
Terayama)

4Ｆ

8Ｆ
OKayamaInternational
CenterExhibition

Postes/Exhibitions

Relaxing and Tea/Coffee (Room 403/404)

Lunch Seminar Companies (Room 403/404)(E) Hot topics 9 Is the concept of embolic
stroke of undertermined source (ESUS)
dead or alive? (Toyoda,
Kitazono=Yamaguchi, Ueno, Yamagami,
Uchiyama, Diener)(J) Special lecture 4 From
Gerontology to Neurology(Sobue=Ouchi)(J) Symposium 20 New Japanese law forstroke medicine social network (Urabe,
Yokota=Minematsu, Ishigami, Takekawa,
Hashimoto)

Room 5 (#302)

2Ｆ

10:00

Room 1 (#405)(E) Web-join

Room 3 (MainHall) (E/J) Webcast

OkayamaConvention
CenterRelaxing and Tea/Coffee (Room 403/404)(J) Educational course １1 Neuroimagingsfor elderly neurological patients(Tomimoto, Sasaki=Sawamoto, Suzuki,
Tomimoto, Ono)

(J) Educational course 13 Clinicopathological conference (Murayama,
Takao=, Tanei < Hasegawa, Suwazono <Beck, Ogata < Abe, Takao < Yamada)(J) Educational course １2 Fromknowledge to understanding of
neuroexamination (Ugawa,
Ichikawa=Kobayashi, Terao, Naito, Ugawa)(J) Educational course 14 Let's learn
more neurorehabilitation (Kowa,
Nogawa=Nakajima, Nozaki, Otsuki, Chuma)(J) LS-19(J) LS-20 (J) LS-21 (J) LS-22 (J) LS-23 (J) LS-24 Cosmic: anti- (J) LS-25 Novartis:(J) LS-26 Eisai: PD
Otsuka: PD &TIMA: Brain Dainippon
Daiichi
Biomerieux: gAChR（Kanda＝Nakane）
Epilepsy（Matsumoto＝(Urushitani＝Takahashi,neuro-inflammation supplement DLB(Washimi Sankyo:
Meningitis
Akamatsu）
Nagayama）（Hirayama＝ Fujimoto）＝Murashima,(Nagai＝Saiki,（Inufusa/Ab ＝Kowa,
Epilepsy（Nakashima(E) LS-27 Eisai: AD (Ono＝(J) LS-28(E) ES-9 Boeringer:(J) ES-10 Medtronics: (J) ES-11 Ono: PD(J) ES-12 (J) ES-13 (J) ES-14 Exhi
Exhibition DOAC & ESUS（Uchiyama Sensing（Tsuboi＝Kimura, (Takahashi＝Takeda）
bitioi
Pasinetti）
Asashikasei:
IQVIA: PD- Alexion: Soliris Chugai: ICI
video ＝Diener)n
PE(Matsuo＝Oji））
Shimo）DMT（Toda＝ for NMOSD(Suzuki＝(Kamei＝Mochiduki）
Torigoe）
vide
Nakashima,

PD-DMT（Toda＝Mochiduki）

Soliris for NMOSD (Kamei＝Nakashima, Kawachi）(J) ES-14 Chugai:
ICI (Suzuki＝Torigoe）

61th of Japanese Society of Neurology（CORONA light style Revised Program 10 version)
September 2 (Wed), 2020
Building

Floor

4Ｆ

Room

3Ｆ

7:00

8:00

9:00

(E) Hot topics 15 Toward Early Diagnosisof ALS (Sonoo, Ugawa=Sonoo, Nodera,
Ugawa, Rogaeva）

Room 2 (#407)(J) Hot topics 16 Cutting edge of Chorea
Research (Kuwabara, Hasegawa=Hamada,
Suzuki, Nambu, Okazawa)(E) WFN (J) Emergent symposium forin CORONA 2 (Abe,
Web casting → CORONA neurologists
Nagayama=Kawamoto, Hira, Yamashita,
report Nagayama)(J) Symposium 52 Neuroinfection, A newera. (Hara, Miura=Kamei, Miura,
Hamaguchi, Matsuura, Hara, Sakiyama)(J) LS-35 FP: PD

4Ｆ

Exhibition(J) Lecture marathon 13
Dementia and small vessel
disease (Yagita=Mizuno)

Lecture Marathon Web
casting →Room 9 (#402)

2Ｆ(#Miki MemorialHall) (E) Web-

1Ｆ(#Kyokusui)(E) WFN

English only Web casting → CORONA
reportRoom 11Web casting for youngs →(J) Web-cast

B1F

Sumitomo: PD（Takahashi＝Hattori, Takeda）(J) Symposium 47 Work Style Reform:
What should we do now? (Takeda,
Misawa=Aiba, Shimohata, Ono)

Room 8 (#401)(J) Web-cast

2F(J) LS-31 Dainippon(J) LS-34 CSL(J) Lecture marathon 14
Dementia clinic in a superaged society(Urakami=Hishikawa)(Morimoto, Narai)(J) Lecture marathon 15
Current topics of MS andNMO (Miyachi=Ochi)(J) Educational course 15 Latest acutestroke management (Koga, Inoue=Saito,
Inoue, Yamagami, Nagao, Kakuda,
Yoshimura)(J) Meet the history: The interesting
history of neurology (Iwata,
Yamawaki=Hirose, Iwata, Fukutake,Takahashi)(E) Ｎｅｕｒｏｓｃｉｅｎｃｅ Ｆｒｏｎｔｉｅｒ Sｙｍｐ 2
Original discovery and therapy for SCA
from Japan to the world (Nagai,
Ishikawa=Nagai, Ohta, Ishikawa, Paulson)(E) Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｅｄｕｃａｔｉｏｎ
Ｃｏｕｒｓｅ 3 (Wei, Rogaeva = AncoliIsrael (Web), Rogaeva, Videnovic,
Paulson)(E) Special oral（clinical）(Katayama, Omote = Yagi, Ichise,
Hattori, Haginesawa, Uchida,
Takizawa, Murate, Matsushima)(E) Special oral（basic） (Furukawa,
Ishiura = Oyagi, Tsujikawa,
Hatayama, Taguchi, Higashi,
Shimizu, Katsumoto, Hujii)(J) Symposium 48 State-of-the-art basic
research for AD (Higuchi, Iwata=Higuchi,
Iwatsubo, Sasaguri, Mano, Takeda)

Room 12(#Event Hall)

Posterpreparation

17 e-posters
presentation(J) Symposium 53 How to manage
dysphagia in Parkinson disease(Yamamoto, Kimura=Yamamoto, Kimura,Nishida, Nitou)

On-site orals (b=8) O04-8～ O-24-9（Kawarabayashi,

Room 14(#Int'l Meeting)On-site orals (c=11) O27-4～O-40-8 （Fujihara,
Morihara）(E) WFN
Clos
CORONAing
report(J) LS-32 Alexion:
MG (Murai＝Suzuki）

Myopathy （Sugie＝Matsui）

Behring: CIDP (Kuwabara＝Misawa）（〇〇＝Tsuboi）

Poster on abstract book （Pj-38-1 ～ Pj57-10、MSP-01-1 ～ MSP-14-9、） Total Removal
312 posters + StP-01-4(J) Lecture marathon 16(J) LS-36 Eisai:
Local clinic neurologists
Eoilepsy （Hirano＝Ihara,
Tanaka）

with a modern device(Fukusako =Kimura)(J) LS-37 Novatis:
MS（Yamamura＝Miyazaki,
Shimizu）(J) LS-38 Glaxo:
EGPA（Takeuchi＝Takeshita）(J) LS-39 Novartis:
Levodopa（Toda＝Watanabe）(E) Emerging Asian Neurology 2(Abe, Lin = Yu, Shang, Lin,
Dezawa, Mehndiratta)(E) WFN
CORONA
report(J) Resident clinicaltournament (on Web)(J) LS-40
Biogen/Eisai: MS (Shimizu＝Nakahara）

Removal(J) LS-41 Ono: AD（Tamaoka＝Mizuno）(J) LS-42 Kyowa

Room 15

Kirin: PD therapy（Ikeda＝
Kashihara）(#Reception Hall)

CORONA
moderate-severestyles(E) Ｎｅｕｒｏｓｃｉｅｎｃｅ Ｆｒｏｎｔｉｅｒ Ｓｙｍｐ 3
Molecular mechanism and therapy for
ALS (Katsuno, Tourenne = Urushitani,
Tourenne, Yamanaka, Katsuno)

History of Chugoku-shikoku area Neurology （Panels）

Room 13 (#1)

16:00

Nichiyaku: CIDP & GBS（Kusunoki＝Chiba）(J) Symposium 51 Current status andfuture of α-synuclein research -up to
date- (Iwatsubo, Ono=Iwatsubo, Ono,
Sato, Mochizuki)(J/E) Web-join(J) Symposium 49 Elucidation ofneurological diseases revealed bybiometal science (Hozumi,
Miyajima=Tsumoto, Nagano, Asanuma,
Hozumi)

15:00(J) LS-30(E) Symposium 46 Cerebral small vessel
disease up-to-date (Kitagawa,Yamashita=Yamashita, Saji, Yoshizawa,
Yakushiji, Itoh)

Postes/Exhibitions

5Ｆ

SMON, ARJP, BAFME, Awaji-ALS, prion
neuropahty, GRP & NMO) (Mizusawa,
Takahashi=Abe, Abe, Takahashi-Hattori, YasudaIshiura, Izumi, Yamashita, Kanda-Shimizu)

14:00

as of August 25, 2020

PD（Ugawa＝Takakusaki,
Iijima）(J) LS-33 JB:

Room 10

OKayamaInternational
Center(E) From the local to the world 2 (JEV,

13:00

Room 5 (#302)

1Ｆ

8Ｆ

On-site orals (a=6)
MSO-01-1～2、StO-0110～02-6 （Furuya,

Relaxing and Tea/Coffee (Room 403/404)(J) LS-29 Takeda:(J) Symposium 50 How to examine
myopathy patients ? (Hamano, Kuru=Kuru,
Hamano, Kimura, Suzuki)

Room 7

Hotel ANA
Okayama

12:00(J) Symposium 45 Infinite possibility of
MRI for clinical practice (Sako,
Tokumaru=Sako, Hatano, Harada, Hayashi)(Exhibition Hall)

4Ｆ

11:00

(E) HOT topics 17 Update of Oligonucleotide Therapy for CNS diseases；
From Basic to Clinic (Yokota,
Toda=Manoharan, Nagata, Kordasiewicz,
Sahashi)(J) Symposium 44 Neurology as a basic
specialty in the Japanese medical
specialty (Toda, Takahashi=Horioka,
Takahashi, Tomimoto, Yamawaki, Ando,
Sonoo)(Reception Hall)

Okayama
Doctors Center

Lunch Seminar Companies (Room 403/404)

Room 4 (#301)

Room 62Ｆ

10:00

Room 1 (#405)(E) Web-join

Room 3 (MainHall) (E/J) Webcast

OkayamaConvention
CenterRelaxing and Tea/Coffee (Room 403/404)

Exhi (J) LS-31 Dainippon Sumitomo: PD
bitioi （Takahashi＝Hattori, Takeda）
nvide

Sponsor only channel A→(J) LS-29 Takeda: PD
Exhibition （Ugawa＝Takakusaki,
video Iijima）

Sponsor only channel B→(J) LS-39 Novartis:
Exhibition (J) LS-38 Glaxo: Levodopa（Toda＝video EGPA（Takeuchi Watanabe）＝Takeshita）(J) LS-32 Exhi (J) LS-34 CSL Behring: (J) LS-35 FP:
Alexion: MG(Murai＝
Suzuki）(J) LS-36 Eisai: (J) LS-37

bitioi CIDP (Kuwabara＝Misawa） PD （〇〇＝Tsuboi） Eoilepsy （Hirano＝nIhara, Tanaka）
vide(J) LS-40(J) LS-41 (J) LS-42(J) LS-43 (E) LS-44
Exhibition Pfaizer:
Ono: ADKyowa: PD
Sanofi: Gosche
Biogen/Eisai: MS
video FAP(Yamashi （Nishikawa＝（Tamaoka＝ （Yamashita(Shimizu＝Nakahara） Mizuno）＝
ta＝Koike） Murayama, Priya

Novatis: MS（Yamamura＝Miyazaki,Shimizu）(J) LS-45

Pfeizer Bristol:DOAC（Shimohama＝Hashimoto,

Clos
ing
Clos
ing

17:00

18:00